Subscribe or Manage Preferences

Value Propositions

  • Bariatric Surgery Before Knee Arthroplasty
  • Adalimumab Proves Most Cost-Effective?
  • Online Reviews from Patients
  • Selective Uric Acid Reabsorption Inhibitor Approved
  • Challenging Step Therapy
Sanofi US has announced that Winthrop US, its generic division, will begin providing an authorized generic version of Arava tablets indicated for the treatment of active rheumatoid arthritis in adults.
As the healthcare system in the United States moves slowly toward a value-based strategy, a recent online article noted that value-based care can lower costs and is certainly beneficial for insurers, including Medicare, but asked, “...does it bring benefits to physicians or patients?”
After reporting on the efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) and opioids in osteoarthritis at the 2015 Osteoarthritis Research Society International World Congress in Seattle, WA, Jeffrey Katz, MD, and colleagues have published online their findings on the cost-effectiveness of NSAIDs in the treatment of older patients with OA and multiple comorbidities.
Nevada has passed a new law designed to help recruit healthcare professionals to the state. As of July 1, the Expedited Licensure Bill allows medical professionals who are licensed and in good standing in another state to receive a license to practice in Nevada within 60 days.
The Centers for Disease Control and Prevention (CDC) has announced that The Lupus Initiative (TLI) will be given a 5-year grant to help fund programs designed to increase knowledge and awareness of systemic lupus erythematosus among primary care practitioners and people with as yet undiagnosed lupus as well as rheumatology healthcare providers.
The first judicial decision to address the 60-day overpayment rule that is part of the Affordable Care Act and the Fraud Enforcement and Recovery Act was handed down in August by the United States District Court for the Southern District of New York.
More than 90% of people with systemic lupus erythematosus (SLE) are women between the ages of 15 and 54 years—encompassing common childbearing years.
The American Board of Internal Medicine (ABIM) has received significant criticism related to the requirements and the increased fees for its maintenance-of-certification (MOC) program.
In September, the American College of Rheumatology (ACR) released new treatment guidelines for polymyalgia rheumatica (PMR).
Page 2 of 21
Results 11 - 20 of 206
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology